We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AC:EURONEXT PARISAccor SA Analysis

Data as of 2026-05-25 - not real-time

$179.24

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Accenture trades around 179.24, well below its DCF-derived fair value of ~367, implying an upside of roughly 38%. The stock’s price‑to‑earnings multiple of 14.7 is markedly cheaper than the industry average of 39.5, while the dividend yield of 3.64% is supported by a modest 51% payout ratio and robust free cash flow. Revenue is growing at 8.3% YoY, margins remain healthy (gross ~32%, operating ~14%), and ROE sits near 25%, underscoring solid profitability. On the technical side, the 20‑day SMA (175.65) sits just below the current price, but both the 50‑day (186.71) and 200‑day (233.12) averages remain higher, indicating a short‑term pullback within a longer‑term downtrend. The MACD histogram is positive (1.62) and the signal line turns bullish, while the RSI hovers around 50, suggesting no immediate overbought pressure. Volatility is elevated at 44% (30‑day) and beta is sub‑market (0.72), pointing to price swings but limited systemic risk.
Overall, the combination of deep valuation discount, sustainable dividend, strong cash generation, and emerging AI partnerships creates a compelling case for accumulation, provided investors can tolerate the near‑term price volatility and bear‑ish trend bias.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Technical bounce indicated by bullish MACD histogram
  • Valuation discount offering ~38% upside
  • Strong cash flow supporting dividend sustainability

Medium Term

1–3 years
Positive
Model confidence: 9/10

Key Factors

  • Continued revenue growth and high ROE
  • Strategic AI and cloud partnerships expanding service addressable market
  • Undervalued relative to peers with solid dividend yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term secular demand for digital transformation services
  • Sustainable dividend and low debt‑to‑equity enhancing financial stability
  • Fundamental valuations far below intrinsic fair value

Key Metrics & Analysis

Financial Health

Revenue Growth8.30%
Profit Margin10.61%
P/E Ratio14.7
ROE24.76%
ROA11.16%
Debt/Equity25.47
P/B Ratio3.5
Op. Cash Flow$13.1B
Free Cash Flow$12.2B
Industry P/E39.5

Technical Analysis

TrendBearish
RSI49.6
Support$155.82
Resistance$184.79
MA 20$175.65
MA 50$186.71
MA 200$233.12
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$367.49
Target Price$247.55
Upside/Downside38.11%
GradeUndervalued
TypeBlend
Dividend Yield3.64%

Risk Assessment

Beta0.72
Volatility44.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.